Text Size
3 studies found for:    22067384 [PUBMED-IDS]

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Recruiting Alemtuzumab to Treat Severe Aplastic Anemia
Conditions: Relapsed or Refractory Severe Aplastic Anemia;   Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath(Registered Trademark))
2 Active, not recruiting Rabbit Antithymocyte Globulin Versus Campath-1H for Treating Severe Aplastic Anemia
Condition: Aplastic Anemia
Interventions: Drug: Alemtuzumab (Campath-1H);   Drug: Thymoglobulin (r-ATG);   Drug: Cyclosporine (CsA)
3 Active, not recruiting Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia
Condition: Severe Aplastic Anemia
Intervention: Drug: Alemtuzumab (Campath)
To Top

† Indicates status has not been verified in more than two years